Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

David Wyles, Fred Poordad, Stanley Wang, Laurent Alric, Franco Felizarta, Paul Y. Kwo, Benedict Maliakkal, Kosh Agarwal, Tarek Hassanein, Frank Weilert, Samuel S. Lee, Jens Kort, Sandra S. Lovell, Ran Liu, Chih Wei Lin, Tami Pilot-Matias, Preethi Krishnan, Federico J. Mensa

Research output: Contribution to journal › Article › peer-review

123 Scopus citations

Fingerprint

Dive into the research topics of 'Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science